Before Saturday, the last time Alessandra Glista saw Laura Ramos was 15 years ago, when they were playing ball hockey ...

Four local school superintendents and a chancellor from Ivy Tech gathered Tuesday to reflect on the local state of education, ...

MicroStrategy rebrands to Strategy, embracing its Bitcoin-focused future and solidifying its position as a top Bitcoin holder ...

Weight loss drugs are huge these days, and Eli Lilly (LLY) is leading the pack when it comes to these. However, today’s leader can become tomorrow’s laggard without continuous development ...

Eli Lilly (LLY) announced results from the VIVID-2 open-label extension study, which showed the majority of patients with moderately to severely active Crohn’s disease receiving two years of ...

The Tennessee high school swimming season is concluding with the TISCA championships. Here are five takeaways from the first ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator instructions] I would now like to turn the conference over to your host, Mike Czapar, ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.

Finding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of ...

Lilly on Thursday reported fourth-quarter revenue of $13.53 billion, a steep 45% increase over the sum the Indianapolis-based drugmaker generated during the same period in 2023.